Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial.

Gabe, Maria Buur Nordskov; Breitschaft, Astrid; Knop, Filip Krag; Hansen, Morten Rix; Kirkeby, Katrine; Rathor, Naveen; Adrian, Charlotte Lindorff

Gabe, Maria Buur Nordskov; Breitschaft, Astrid; Knop, Filip Krag; Hansen, Morten Rix; Kirkeby, Katrine; Rathor, Naveen; Adrian, Charlotte Lindorff.

Afiliação

Gabe MBN; Novo Nordisk A/S, Søborg, Denmark.
Breitschaft A; Parexel International GmbH, Berlin, Germany.
Knop FK; Novo Nordisk A/S, Søborg, Denmark.
Hansen MR; Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Kirkeby K; Steno Diabetes Center Copenhagen, Herlev, Denmark.
Rathor N; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Adrian CL; Novo Nordisk A/S, Søborg, Denmark.

Diabetes Obes Metab ; 2024 Jul 31.

Article em En | MEDLINE | ID: mdl-39082206

Palavras-chave

GLP1 analogue; antiobesity drug; appetite control; clinical trial; obesity therapy; semaglutide

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Diabetes Obes Metab Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google